Inventisbio
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Clive Hills Rd, Short Hills, New Jerse...Phone Number
(908) 370-5826Website
www.inventisbio.comRevenue
$13.3 MillionIndustry
About Inventisbio
益方生物科技（上海）股份有限公司 focuses on the development of innovative drugs for major diseases, particularly in the fields of tumor autoimmune diseases and metabolic disorders. The company has successfully launched two innovative drugs and has three candidate drugs currently in clinical trials, with two core products undergoing phase III clinical trials. They are committed to advancing drug development targeting synthetic lethal pathways, autoimmune targets, kinases, and tumor driver genes. Their pipeline includes a range of preclinical candidate compounds across multiple therapeutic areas.Explore more
SIC Code 28,283NAICS Code 32,325Show more
Inventisbio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Inventisbio
Compare insights from companies similar to Inventisbio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Inventisbio Tech Stack
A closer look at the technologies used by Inventisbio
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inventisbio
Sign Up For FreeTo access detailed company insights
益方生物科技（上海）股份有限公司 focuses on the development of innovative drugs for major diseases, particularly in the fields of tumor autoimmune diseases and metabolic disorders. The company has successfully launched two innovative drugs and has three candidate drugs currently in clinical trials, with two core products undergoing phase III clinical trials. They... Read More
